Evidence update · 2026-08-28

How good is the 20-week heart screen?

Evidence CHECKED 2026-08-28

The short answer

Prenatal detection of major heart defects ranges from under 20% to over 80% depending on country, training, and scanning protocol - it is a range, not a single number. A missed finding reflects the limits of the screening exam, not a failure of anyone. Adding outflow-tract views roughly doubles detection; that is why guidelines now require them.

Parents who learn their baby's heart condition only after birth often ask the same painful question: why didn't the scan see it? The honest answer lives in registry data, and it is more forgiving - and more complicated - than most families are told.

What the data shows

The collaborative registry work associated with this domain's former occupant (IPAK-CARD and the international groups around it) analyzed prenatal detection across many centers and countries. The headline findings, consistent with wider European registry literature:

Detection is a range, not a number. Across programs, prenatal detection of major CHD spans roughly from under 20% to over 80% depending on country, training, equipment, and whether outflow-tract views are routine.
Which views are used matters enormously. Adding outflow-tract views to the basic four-chamber screen roughly doubles the detection of major lesions - this is why guidelines now specify them.
Some lesions hide well. Even excellent programs miss a share of lesions that develop late or are subtly positioned; total prenatal detection of all CHD (most of which is minor) is necessarily much lower than detection of major CHD.
Geography is destiny, unfairly. The same fetus with the same heart has very different detection odds depending on where the mother lives and which screening program she is in.

Sources (checked 2026-08-28)

Respondek-Liberska et al., IPAK-CARD collaborative analysis, Journal of Perinatal Medicine, PMCID: PMC4368244; ISUOG Practice Guidelines (updated): sonographic screening examination of the fetal heart (UOG 2013), and the current update, fetal cardiac screening (UOG 2023); European registry literature summarized therein.

Why this matters to families

A finding discovered at birth rather than at 20 weeks changes the pathway - delivery may not have been planned at a cardiac center, and the first hours become more urgent. It does not usually change the heart itself. Parents should hear both halves of that sentence.

What this site does with this

Our Screening stage page reflects this evidence: screening is described as deliberately sensitive but incomplete, and "a normal scan is a good sign, not a guarantee" is stated plainly. We will update this entry when new registry analyses or guideline revisions publish; the CHECKED date above tells you how current it is.

Common questions

Why didn't the 20-week scan see my baby's heart problem?

Detection of major CHD varies enormously between programs - from under 20% to over 80%. Some lesions develop or become visible later in pregnancy; others are subtly positioned. A missed finding is a known limitation of screening, not anyone's failure.

How accurate is the fetal heart screening scan?

For major defects, detection spans roughly 20-80%+ across countries and programs. Programs using outflow-tract views in addition to the four-chamber view detect roughly twice as many major lesions. Detection of all CHD (mostly minor) is necessarily lower than detection of major CHD.

Does a missed finding change my baby's outcome?

It changes the pathway - delivery may not have been planned at a cardiac center, making the first hours more urgent. It does not usually change the heart itself. Both halves of that sentence matter.